Chatbots for Mental Health & Therapy Market Projected to Expand at 5.6% CAGR Through 2033

Chatbots for Mental Health & Therapy Market Size Expected to Reach USD 2.2 Billion by 2033

Overview

The Global Chatbots for Mental Health & Therapy Market size is expected to be worth around USD 2.2 Billion by 2033, from USD 1.3 Billion in 2023, growing at a CAGR of 5.6% during the forecast period from 2024 to 2033.

The growing demand for accessible mental health support is encouraging wider adoption of AI-powered chatbots that provide immediate, text-based emotional assistance, self-guided therapy exercises, mood tracking, and mental wellness resources. These tools are increasingly being used to complement traditional mental health services by offering 24/7 availability, reducing waiting times, and improving access for people living in underserved or remote areas.

Healthcare providers and digital health developers are also integrating conversational AI into telehealth platforms to support patient engagement and routine mental wellness monitoring. However, experts continue to emphasize that chatbots should supplement, rather than replace, qualified mental health professionals.

Trusted healthcare organizations are supporting responsible innovation while highlighting the need for clinical validation, privacy protection, and safety standards. According to the World Health Organization (WHO), around 970 million people worldwide were living with a mental disorder in 2019, with anxiety and depression accounting for a significant proportion of cases.

Meanwhile, the National Institute of Mental Health (NIMH) advises users to carefully evaluate mental health apps because there are currently no national standards for assessing the effectiveness of many digital mental health tools. These recommendations are encouraging developers to focus on evidence-based design, transparent data practices, and clinician oversight, helping strengthen trust in chatbot-assisted mental healthcare while supporting the broader expansion of digital behavioral health solutions.

Key Takeaways

The global Chatbots for Mental Health & Therapy Market is forecast to grow from USD 1.3 billion in 2023 to approximately USD 2.2 billion by 2033, reflecting the increasing adoption of AI-powered mental health support solutions worldwide.
The market is expected to register a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2024 to 2033, driven by rising demand for accessible and digital mental healthcare services.
Among technologies, the machine learning and deep learning segment led the market in 2023, accounting for a 58.7% share, as healthcare providers increasingly adopted advanced AI capabilities to deliver personalized mental health support.
By component, the Software-as-a-Service (SaaS) segment dominated the market with a 74.3% revenue share in 2023, supported by the growing preference for cloud-based, scalable, and cost-effective mental health platforms.
Based on application, the conversational interface segment captured a substantial 63.7% market share in 2023, highlighting the strong demand for chatbot-driven interactions that provide immediate and user-friendly mental health assistance.
Regionally, North America maintained its leading position in the global market, securing a 41.6% share in 2023, supported by advanced digital healthcare infrastructure, high adoption of AI technologies, and growing awareness of mental wellness.

Statistical Information

More than 1 billion people worldwide are living with a mental health condition, highlighting the urgent need for scalable digital mental health solutions such as AI-powered chatbots.
In the United States, 59.3 million adults (23.1%) experienced any mental illness (AMI) in 2022, creating substantial demand for accessible digital mental health support outside traditional clinical settings.
The 18–25 age group recorded the highest prevalence of mental illness in the U.S., with 36.2% of young adults experiencing any mental illness in 2022, making them one of the primary users of digital mental health platforms.
An estimated 15.4 million U.S. adults were living with serious mental illness (SMI) in 2022, representing 6.0% of the adult population and increasing the need for continuous digital monitoring and support technologies.
The National Institute of Mental Health (NIMH) reports that 29% of all health-related mobile applications are focused on mental health, demonstrating the rapid expansion of digital behavioral health technologies.
The World Health Organization’s Mental Health Atlas 2024 collected mental health system data from 144 countries, reflecting the growing global focus on digital mental healthcare, telehealth, and AI-enabled services.
According to the National Institute of Mental Health (NIMH), there are hundreds of mental health apps available today, but no national standards currently exist for evaluating their effectiveness, driving demand for clinically validated AI chatbot solutions.
The 988 Suicide & Crisis Lifeline in the U.S. provides 24/7 access through call, text, and chat, reflecting the increasing acceptance of conversational digital platforms for delivering immediate mental health support.

Market Segmentation Analysis

Technology Analysis: Based on technology, the machine learning and deep learning segment accounted for the largest share of 58.7% in the global Chatbots for Mental Health & Therapy Market in 2023. The segment’s leadership is supported by its ability to analyze behavioral patterns, personalize user interactions, and assist in identifying early signs of mental health concerns. The U.S. National Institute of Mental Health (NIMH) notes that AI-powered digital tools can monitor behavioral changes and enhance mental health support, although they should complement not replace professional care. These capabilities continue to strengthen adoption across digital mental health platforms.
Component Analysis: Based on component, the Software-as-a-Service (SaaS) segment captured a dominant 74.3% revenue share in 2023. Cloud-based deployment enables healthcare organizations to rapidly implement chatbot solutions while reducing infrastructure costs and improving scalability. SaaS platforms also simplify software updates, remote access, and secure data management. According to the National Institute of Mental Health (NIMH), digital mental health technologies are increasingly supporting symptom monitoring, patient engagement, and therapy access, driving greater demand for cloud-based mental health applications across healthcare systems.
Application Analysis: Based on application, the conversational interface segment held the largest market share of 63.7% in 2023. AI-powered conversational systems use natural language processing to provide real-time interactions, mental wellness guidance, and self-management support through text or voice. According to the National Institute of Mental Health (NIMH), conversational digital tools can extend mental health support beyond traditional clinical settings by improving accessibility and user engagement. Their ability to deliver immediate responses and personalized experiences continues to encourage adoption across digital behavioral health services.

Regional Analysis

North America dominated the global Chatbots for Mental Health & Therapy Market, accounting for 41.6% of the market share in 2023. The region’s leadership is supported by advanced healthcare IT infrastructure, strong adoption of artificial intelligence, and increasing investment in digital behavioral health solutions.

The U.S. National Institute of Mental Health (NIMH) continues to support research on digital mental health technologies, including AI-based tools that improve screening, treatment access, and patient engagement while emphasizing responsible and evidence-based implementation. In addition, growing awareness of mental health and supportive innovation policies have accelerated the adoption of chatbot-enabled care across the United States and Canada.

Asia-Pacific is expected to witness significant growth during the forecast period due to the increasing need for scalable mental healthcare solutions and a shortage of mental health professionals in several countries.

The World Health Organization (WHO) is promoting chatbot-based stress management tools through its Be He@lthy, Be Mobile initiative, while UNICEF has introduced the Safer Chatbots Implementation Guide to help organizations deploy AI chatbots safely, particularly for children and other vulnerable populations. These initiatives are expected to encourage wider adoption of digital mental health technologies across the region.

Business Opportunities

The Chatbots for Mental Health & Therapy Market offers strong business opportunities as healthcare systems increasingly adopt digital solutions to improve access to mental health services. AI-powered chatbots can support early screening, symptom monitoring, patient education, and follow-up care, helping providers extend services beyond traditional clinical settings.

The U.S. National Institute of Mental Health (NIMH) continues to promote research into digital mental health technologies that improve prevention, diagnosis, treatment, and long-term management of mental disorders using AI and mobile platforms. These initiatives create opportunities for software developers, healthcare providers, and technology companies to build clinically validated chatbot solutions.

Further opportunities exist in integrating chatbots with telehealth platforms, electronic health records, wearable devices, and employer wellness programs to deliver personalized mental health support. The World Health Organization (WHO) has also introduced AI-enabled digital health initiatives, highlighting the growing role of conversational AI in expanding access to reliable health information.

Companies investing in multilingual capabilities, privacy protection, regulatory compliance, and evidence-based chatbot design are well positioned to meet the rising demand from hospitals, insurers, educational institutions, and public health organizations. As digital mental health adoption accelerates globally, partnerships with healthcare providers and government agencies are expected to unlock new revenue streams and strengthen long-term market growth.

Emerging Trends

AI chatbots are becoming predictive rather than reactive. Modern mental health applications increasingly use smartphone sensors and behavioral data to identify changes in sleep, activity, or communication patterns before a mental health crisis develops. The U.S. National Institute of Mental Health (NIMH) highlights that these technologies can detect behavioral changes and trigger timely support, creating demand for more intelligent, preventive chatbot platforms.
Governments are introducing stronger oversight for AI mental health tools. In 2025, the U.S. FDA began evaluating AI-enabled mental health devices, including chatbot-based digital therapies, to address safety, transparency, and clinical effectiveness. This regulatory focus is encouraging developers to invest in clinically validated chatbot solutions instead of general-purpose conversational AI.
Youth-focused digital mental health solutions are gaining priority. The WHO Europe released guidance outlining 8 priority policy actions to improve young people’s mental health in digital environments. This is driving the development of age-appropriate chatbot platforms with stronger privacy controls, safer interactions, and responsible AI features for adolescents and young adults.
Mental health platforms are expanding beyond chat into multimodal AI. Developers are combining text, voice, wearable devices, and digital biomarkers to deliver more personalized support. NIMH reports that smartphones and connected devices now help monitor symptoms and deliver interventions based on an individual’s real-time condition, improving engagement and continuity of care.
Healthcare organizations are emphasizing evidence-based AI development. Public health agencies increasingly recommend that chatbot developers validate clinical performance, strengthen privacy safeguards, and maintain professional oversight before deployment. This trend is creating opportunities for healthcare providers and AI companies to collaborate on trusted, regulated mental health technologies.

Use Cases

AI chatbots are increasingly being used as prescription digital therapeutics for depression. In a recent FDA discussion, an example digital therapy was designed for adults aged 22 years and older with major depressive disorder (MDD) who were not engaged in therapy. The FDA is developing regulatory frameworks to ensure these AI-based therapeutic chatbots are safe, clinically effective, and appropriate for home-based mental health treatment under healthcare provider supervision.
Personalized monitoring for depression and anxiety is expanding through AI-powered mobile platforms. NIMH notes that smartphone-based tools continuously monitor user behavior and can alert users or providers when meaningful behavioral changes indicate worsening mental health, supporting earlier intervention and improved patient outcomes.
Hospitals and healthcare providers are adopting AI chatbots to reduce workforce shortages. The FDA recognizes that AI-based mental health devices can help address limited access to mental health professionals by supporting routine assessments, patient engagement, and therapy follow-ups under appropriate clinical oversight.
Digital self-management programs are becoming increasingly common. AI chatbots now assist users with stress reduction, symptom tracking, medication reminders, and behavioral coaching through continuous conversations. These tools improve patient engagement between clinical appointments while supporting long-term management of common mental health conditions.
Public health agencies are using AI to expand access to mental healthcare. The WHO is encouraging responsible digital mental health solutions that reach underserved populations while promoting safe AI implementation. These initiatives are accelerating chatbot adoption across community health programs, telehealth services, and preventive mental healthcare worldwide.

Recent Developments

In February 2026, Wysa received a £5.3 million Wellcome grant to support a scale-up study adapting its clinically validated digital mental-health intervention for adolescent girls in rural India.
In January 2026, Biobeat announced a strategic collaboration with Kestra Medical Technologies, including a $5 million equity investment, to integrate its cuffless blood-pressure monitoring into Kestra’s wearable defibrillator system.
In December 2025, Biobeat secured $50 million in Series B financing led by Ally Bridge Group, OrbiMed Advisors, and Elevage Medical Technologies to accelerate U.S. commercialization.
In July 2025, Lyra Health completed a $235 million financing led by Dragoneer, with Salesforce Ventures joining, to support international expansion.
In July 2025, Woebot Health reportedly closed a $90 million Series B round, bringing total funding to about $114 million, with JAZZ Venture Partners and Temasek as co-leads.
In March 2025, Wysa acquired April Health to combine its AI mental-health chatbot with primary-care-integrated behavioral health services and broaden access through clinician-supported care.

Frequently Asked Questions About Chatbots for Mental Health & Therapy

What factors are driving the growth of this market?
The market is expanding due to rising mental health awareness, shortages of qualified mental health professionals, increasing smartphone usage, and wider adoption of digital healthcare services. Healthcare organizations are also investing in AI-enabled technologies that improve patient engagement and expand access to behavioral health support.
How do AI mental health chatbots work?
AI mental health chatbots use natural language processing and machine learning to understand conversations, provide coping strategies, monitor emotional well-being, and recommend appropriate resources. Some advanced platforms also analyze behavioral patterns through smartphone data to help identify changes that may require additional mental health support.
Can mental health chatbots replace therapists?
Mental health chatbots are designed to support, not replace, licensed mental health professionals. They assist with symptom tracking, education, and routine guidance, while diagnosis, crisis management, and treatment planning should continue to be provided by qualified healthcare providers.
Which healthcare settings are adopting mental health chatbots?
Mental health chatbots are increasingly being adopted by hospitals, behavioral health clinics, telehealth providers, educational institutions, employers, and insurance organizations. They help improve patient communication, automate follow-ups, deliver wellness information, and extend mental health services to underserved populations.
Which technologies are shaping the future of this market?
Machine learning, natural language processing, generative AI, speech recognition, predictive analytics, and wearable device integration are transforming mental health chatbots. These technologies enable personalized interactions, continuous monitoring, early symptom detection, and improved engagement across digital behavioral healthcare services.
What opportunities exist for companies in the Chatbots for Mental Health & Therapy Market?
Companies can capitalize on opportunities by developing clinically validated chatbot platforms, integrating AI with telehealth and electronic health records, enhancing multilingual capabilities, and strengthening cybersecurity. Strategic collaborations with healthcare providers, insurers, and public health organizations can further accelerate adoption and long-term market growth.

Conclusion
The Chatbots for Mental Health & Therapy Market is steadily evolving as healthcare systems increasingly adopt AI-powered solutions to improve access, engagement, and continuity of mental health care. Advances in machine learning, natural language processing, and cloud-based platforms are enabling more personalized and scalable digital support while complementing traditional clinical services.

Government agencies and trusted healthcare organizations continue to promote responsible AI development through research, clinical validation, and regulatory oversight. As investments in digital health, telehealth integration, and evidence-based technologies continue to grow, the market is expected to create significant opportunities for technology providers, healthcare organizations, and public health systems worldwide.